ESiOR´s CEO Erkki Soini, one of the speakers at the Digital Health Society Summit
We are excited to announce that Erkki Soini will be speaking at the Digital Health Society Summit on November 6th, under the theme “Who Are
21.10.2024
The Finngenious Symposium convened a diverse group of professionals
On September 30, 2024, over 400 professionals gathered for a symposium organized by the Finnish Biobank Cooperative- FINBB and Fingenious. The symposium convened medical, biotechnology,
14.10.2024
Wellbeing services counties & pharmaceutical treatment 2024
Are you interested to hear how reforming pharmaceutical care and pharmaceutical financing as well as guidance and evaluation have started to be implemented both nationally
7.10.2024
Cardiovascular diseases represent a significant concern in Finland
Janne Martikainen (ESiOR Oy) discusses the topic on MTV3’s Huomenta Suomi program In the interview, the treatment and prevention of cardiovascular diseases and the financial
1.10.2024
The pharmaceutical work by the pharmacies holds immense societal value
Pharmaceutical work provided by Finnish community pharmacies save wellbeing service counties about 855 million euros in health services per year In an evaluation we conducted
24.9.2024
Self-care counselling by community pharmacies reduces the public health care provider costs
Assessment: Self-care counselling carried out by the Finnish community pharmacies provides wellbeing service counties with more than half a billion euros of savings In an
9.8.2024
Threefold cost in high-risk heart patients – a SPESiOR study
The link between the risk of myocardial infarction recurrence and the costs of health and social services has been demonstrated in a study conducted in
2.8.2024
The value of pharmaceutical research for patients, healthcare and society
The value of one drug trial for healthcare is up to EUR 10 million According to a study we at ESiOR carried out together with
2.8.2024
AI x Pharma x RWE chairman
Chairing education related to artificial intelligence (AI) for real-world evidence (RWE) at AI x Pharma x Health 2024: “Explore the potential of artificial intelligence in
13.3.2024
AI predictions and use of genetic information: Cost-effectiveness. Secure processing environment and EHDS: Comparison. ISPOR US
Multiple new ESiOR innovations are presented during the International Society for Pharmacoeconomics and Outcomes Research (ISPOR US) main congress at Atlanta in the Unites States
4.3.2024
GenomiTerveys project receives Biobank Research of the Year Award
The GenomiTerveys project, led by the Helsinki Biobank, has received the first-ever Biobank Research of the Year award from the Finnish Biobank Cooperative – FINBB.
15.12.2023
